It offers BAQSIMI, a nasal spray for the treatment of severe hypoglycemia; Primatene Mist, an over-the-counter epinephrine inhalation product for the temporary relief of mild symptoms of ...

It offers BAQSIMI, a nasal spray for the treatment of severe hypoglycemia; Primatene Mist, an over-the-counter epinephrine inhalation product for the temporary relief of mild symptoms of ...

Amphastar's Q4 sales grew 20% to $186.5M, missing estimates. Primatene MIST surpassed $100M in annual sales, while Baqsimi saw strong growth.

Amphastar Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration has granted approval for the Company's Abbreviated New Drug Application for Albuterol Sulfate Inhalation Aerosol, ...

Amphastar Pharmaceuticals is focused on developing and selling injectable, inhalation, and intranasal products. See why I rate AMPH stock as a buy.

Operator: Greetings and welcome to the Amphastar Pharmaceuticals' First Quarter Earnings Call. At this time, all participants are in a listen-only mode.

Dr. Bowser agrees, adding that other OTC asthma treatments, like Primatene Mist, have side effects of increasing your heart rate while symptom relief is short-lived.

Primatene Mist is an epinephrine inhalation product, which is indicated for the temporary relief of mild symptoms of intermittent asthma.

Once again, we attribute this success to our key, high-margin Primatene MIST, glucagon and epinephrine products, seeing notable increases for sustained growth.